The Business Times
SUBSCRIBERS

Samsung Bioepis partners Takeda to develop original biotech drugs

Published Mon, Aug 21, 2017 · 09:50 PM
Share this article.

Seoul

SAMSUNG Bioepis Co Ltd said on Monday that it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs.

Original biotech drugs represent a business ramp-up for Samsung Bioepis, which has so far invested US$1.3 billion in drug development since being founded in 2012 and has received…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here